Literature DB >> 6027217

Coronary disease in familial hypercholesterolemia.

J Jensen, D H Blankenhorn, V Kornerup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6027217     DOI： 10.1161/01.cir.36.1.77

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

1.  Family similarities in the age at coronary death in familial hypercholesterolaemia.

Authors:  A Heiberg; J Slack
Journal:  Br Med J       Date:  1977-08-20

2.  Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Authors:  Amanda M Perak; Hongyan Ning; Sarah D de Ferranti; Holly C Gooding; John T Wilkins; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 3.  Lipid lowering drugs and hyperlipidaemia.

Authors:  R I Levy; B M Rifking
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  [Electrocardiographic examination in patients with skin diseases].

Authors:  R Denk
Journal:  Arch Kreislaufforsch       Date:  1969-10

5.  Mutants, hyperlipoproteinaemia, and coronary artery disease.

Authors:  D S Fredrickson
Journal:  Br Med J       Date:  1971-04-24

6.  Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance.

Authors:  I Yokoyama; K Yonekura; Y Inoue; K Ohtomo; R Nagai
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

7.  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  BMJ       Date:  1991-10-12

8.  Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.

Authors:  B P Way; M J Ball; M Thorogood; S M Cobbe; J I Mann
Journal:  J R Soc Med       Date:  1986-07       Impact factor: 5.344

9.  Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

Authors:  D R Illingworth; G J Sexton
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.

Authors:  P Weisweiler; W Merk; B Jacob; P Schwandt
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.